A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant bacteria, according to new clinical trial results. Two intravenous doses of the ...

Study shows efficacy and safety of oral antibiotic therapy in the form of pills for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An international ...

MRSE and MRSA are bacterial infections caused by the Staphylococcus genus. These infections are resistant to several types of antibiotics, making them more difficult to treat. They can cause serious ...

LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on pathogen-specific ...

Methicillin-resistant Staphylococcus epidermidis (MRSE) is a drug-resistant form of staph bacteria. MRSE infections may be difficult to treat due to their resistance to methicillin and other common ...

Lincoln, Neb. — Researchers at the University of Nebraska–Lincoln are working to halt resistance to an antibiotic used to treat serious staph infections in humans. Staphylococcus aureus is a bacterium ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." There are plenty of infections that you get on a regular basis, such as a cold or a stomach bug, and ...

Add Yahoo as a preferred source to see more of our stories on Google. The National Institute of Allergy and Infectious Diseases said a new treatment for bloodborne staph infections showed promise in a ...

Topline data anticipated in Q1 2025 to support potential initiation of a pivotal bacteremia efficacy trial in 2025 LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (ARMP) ...